Publications
5532 Results
- Journal / Conference
- Cancer 70(10):2547-2551
- Year
- 1992
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8731
A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group study.
- Journal / Conference
- Journal of Immunotherapy 3:176-183
- Year
- 1992
- Research Committee(s)
- Developmental Biologics
- Study Number(s)
- SWOG-8801
A Southwest Oncology Group phase I study of sequential combination of recombinant interferon-y and recombinant interleukin-2 in patients with cancer.
- Journal / Conference
- Gyn Onc 44:66-70
- Year
- 1992
- Research Committee(s)
- Developmental Biologics
- Study Number(s)
- SWOG-8825
Melphalan GM-CSF: A phase I study.
- Journal / Conference
- JCO 10(3):428-432
- Year
- 1992
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8294 (INT-0011) (EST-1180)
Prognostic significance of S-Phase fraction in good risk node-negative breast cancer patients.
- Journal / Conference
- Leukemia 6(7):708-714
- Year
- 1992
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-7823/24/25/26
Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia-results of a Southwest Oncology Group study of rubidazone vs adriamycin for remission induction, prophylactic intrathecal therapy, late intensifica- tion, and levamisole maintenance.
- Journal / Conference
- JCO 10(8):1284-1291
- Year
- 1992
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8228
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: Results of a prospective Southwest Oncology Group study.
- Journal / Conference
- Journal of the National Cancer Institute Monographs 11:97-104
- Year
- 1992
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8294 (INT-0011) (EST-1180)
Chemotherapy versus observation in high-risk node-negative breast cancer patients.
- Journal / Conference
- Human Pathology 23(9):974-979
- Year
- 1992
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8696 (INT-0076) (EST-7186)
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.
- Journal / Conference
- JCO 10(5):706-717
- Year
- 1992
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8412
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Final report by the Southwest Oncology Group of a phase III randomized trial in stages III (suboptimal) and IV ovarian cancer.
- Journal / Conference
- JCO 10(8):1245-1251
- Year
- 1992
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-8514